Trials / Conditions / Salivary Gland Tumors

Salivary Gland Tumors

6 registered clinical trials studyying Salivary Gland Tumors — 3 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	An International Study on Pediatric Patients With Rare Tumors. NCT07072143	Azienda Ospedaliera di Padova	—
Unknown	Phase II Study of RC48-ADC in Treating Patients With Salivary Gland Tumors Expressing HER2 NCT05601401	Peking Union Medical College Hospital	Phase 2
Recruiting	Neoadjuvant Sintilimab in Combination With Carboplatin and Nab-paclitaxel in Untreated Salivary Gland Malignan NCT05000892	Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University	Phase 2
Not Yet Recruiting	Neoadjuvant Toripalimab in Combination With Carboplatin and Nab-paclitaxel in Untreated Salivary Gland Maligna NCT04825938	Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University	Phase 2
Completed	Postoperative Concurrent Chemoradiotherapy in Treating Patients With High-Risk Salivary Gland Carcinomas NCT02776163	Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University	Phase 2
Completed	Concurrent Chemotherapy Based on Genetic Testing in Patients With High-Risk Salivary Gland Tumors NCT02921984	Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University	Phase 1